Growth Metrics

ENDRA Life Sciences (NDRA) Operating Margin: 2016-2018

Historic Operating Margin for ENDRA Life Sciences (NDRA) over the last 2 years, with Mar 2018 value amounting to -45,960.77%.

  • ENDRA Life Sciences' Operating Margin was N/A to -45,960.77% in Q1 2018 from the same period last year, while for Mar 2018 it was -1,984.92%, marking a year-over-year change of. This contributed to the annual value of -9,971.19% for FY2024, which is 768648.00% down from last year.
  • Latest data reveals that ENDRA Life Sciences reported Operating Margin of -45,960.77% as of Q1 2018, which was down 37.09% from -33,526.58% recorded in Q4 2017.
  • ENDRA Life Sciences' 5-year Operating Margin high stood at 249,652.53% for Q2 2016, and its period low was -45,960.77% during Q1 2018.
  • Moreover, its 3-year median value for Operating Margin was -317.40% (2017), whereas its average is 24,016.98%.
  • Data for ENDRA Life Sciences' Operating Margin shows a maximum YoY slumped of 25,148,188bps (in 2017) over the last 5 years.
  • Quarterly analysis of 3 years shows ENDRA Life Sciences' Operating Margin stood at -61.85% in 2016, then slumped by 3,346,474bps to -33,526.58% in 2017, then reached -45,960.77% in 2018.
  • Its Operating Margin was -45,960.77% in Q1 2018, compared to -33,526.58% in Q4 2017 and -317.40% in Q3 2017.